Drug candidates spanning oncology, neurology, rare diseases and more are approaching critical development as the calendar turns to 2026.
Sanofi’s pharma focus, strong Dupixent growth, and valuation discount position it for upside amid buybacks and rising ...
Discover why SANG stands out as an SMB-focused UCaaS provider with industry-low churn, high margins, and strong long-term ...
For most business leaders, the sales team is the engine that drives growth. But even the best engines need regular tuning. In ...
Sharply higher costs in all categories—particularly material, which roughly doubled—increased the estimated price of building ...
SG&A Reduced Over $1 Million During Same Period Comparison, Q2 Confirmed Overall Profitable Detroit, Michigan–(Newsfile Corp.
CISO Global (NASDAQ: CISO) a leading provider of AI-powered cybersecurity software and compliance services, today announced it is well-positioned to accelerate sales growth and pursue strategic ...
India's senior population is set to surpass 347 million by 2050, fueling a $ 50 Billion 'Silver Economy' for elderly care.
Sable Offshore Corp. is looking to pivot away from a fraught network of pipelines that have faced increasing legal and ...